Dan Oren

Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.

Dexcel Pharma Ltd. develop, manufacture and market value-added branded and generic pharmaceuticals. The company was founded by Dan Oren in 1968 and is headquartered in Northamptonshire, the United Kingdom.

Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.

Dexcel Pharma Technologies Ltd. develops, manufactures and markets branded and generic pharmaceuticals. Its core products include Deximune, PerioChip, and Omeprazole delayed released tablet. The company was founded by Dan Oren in 1968 and is headquartered in Or Akiva, Israel.

Part of Dexcel Ltd., Dexcel Pharma GmbH is a German pharmaceutical company that aims to promote health through the production of high-quality and safe drugs for the treatment of acute and chronic diseases. The company is based in Alzenau, Germany. The CEOs are Henning Hoffmeyer, Anastasis Konstantinou, Dan Oren. The company was founded in 1993.

Part of Dexcel Ltd., Dexcel Pharma GmbH is a German pharmaceutical company that aims to promote health through the production of high-quality and safe drugs for the treatment of acute and chronic diseases. The company is based in Alzenau, Germany. The CEOs are Henning Hoffmeyer, Anastasis Konstantinou, Dan Oren. The company was founded in 1993.